Induction of autophagy with catalytic mTOR inhibitors reduces huntingtin aggregates in a neuronal cell model
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Induction of autophagy with catalytic mTOR inhibitors reduces huntingtin aggregates in a neuronal cell model
Authors
Keywords
-
Journal
JOURNAL OF NEUROCHEMISTRY
Volume 119, Issue 2, Pages 398-407
Publisher
Wiley
Online
2011-08-20
DOI
10.1111/j.1471-4159.2011.07435.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dual mTORC2/mTORC1 Targeting Results in Potent Suppressive Effects on Acute Myeloid Leukemia (AML) Progenitors
- (2011) J. K. Altman et al. CLINICAL CANCER RESEARCH
- Small Changes, Big Impact
- (2011) Dagmar E. Ehrnhoefer et al. NEUROSCIENTIST
- Vertical Targeting of the Phosphatidylinositol-3 Kinase Pathway as a Strategy for Treating Melanoma
- (2010) S. A. Aziz et al. CLINICAL CANCER RESEARCH
- Chaperone-mediated autophagy in protein quality control
- (2010) Esperanza Arias et al. CURRENT OPINION IN CELL BIOLOGY
- Proteolysis of Mutant Huntingtin Produces an Exon 1 Fragment That Accumulates as an Aggregated Protein in Neuronal Nuclei in Huntington Disease
- (2010) Christian Landles et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's disease
- (2010) Jonathan H Fox et al. Molecular Neurodegeneration
- A small-molecule scaffold induces autophagy in primary neurons and protects against toxicity in a Huntington disease model
- (2010) A. S. Tsvetkov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- mTORC1 signaling: what we still don't know
- (2010) X. Wang et al. Journal of Molecular Cell Biology
- Single-step detection of mutant huntingtin in animal and human tissues: A bioassay for Huntington’s disease
- (2009) Andreas Weiss et al. ANALYTICAL BIOCHEMISTRY
- Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR)
- (2009) Juan M. García-Martínez et al. BIOCHEMICAL JOURNAL
- AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity
- (2009) C. M. Chresta et al. CANCER RESEARCH
- Inducible mutant huntingtin expression in HN10 cells reproduces Huntington's disease-like neuronal dysfunction
- (2009) Andreas Weiss et al. Molecular Neurodegeneration
- Small molecule enhancers of autophagy for neurodegenerative diseases
- (2008) Sovan Sarkar et al. Molecular BioSystems
- Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
- (2008) S.-M. Maira et al. MOLECULAR CANCER THERAPEUTICS
- Autophagy fights disease through cellular self-digestion
- (2008) Noboru Mizushima et al. NATURE
- Regulation of macroautophagy by mTOR and Beclin 1 complexes
- (2007) Sophie Pattingre et al. BIOCHIMIE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More